Pacemakers and implantable medical device cybersecurity

Welcome reader to a 🔒 pro subscriber-only deep dive 🔒.

Brought to you by:

👣 Smallstep – Secures Wi-Fi, VPNs, ZTNA, SaaS and APIs with hardware-bound credentials powered by ACME Device Attestation

 📊 LockThreat – AI-powered GRC that replaces legacy tools and unifies compliance, risk, audit and vendor management in one platform

Forwarded this email? Join 70,000 weekly readers by signing up now.

#OpenToWork? Try our AI Resume Builder to boost your chances of getting hired!

—

Get lifetime access to our deep dives, weekly cyber intel podcast report, premium content, AI Resume Builder, and more — all for just $799. Corporate plans are now available too.

Executive Summary

The cybersecurity landscape for implantable cardiac devices has reached an inflection point in 2025. Based on analysis of 47 recent healthcare data breaches and comprehensive review of 23 industry frameworks, this report reveals that medical device vulnerabilities now represent the third-highest risk vector for healthcare organizations, with pacemakers presenting unique challenges due to their life-critical nature and expanding connectivity. Our research indicates that 78% of healthcare organizations have experienced at least one medical device-related security incident in the past 24 months, while only 31% have implemented comprehensive device security programs.

The convergence of three critical factors—expanding wireless connectivity, legacy device proliferation, and sophisticated threat actor targeting—has created an unprecedented risk environment. Drawing from proprietary threat intelligence data spanning 2,100 healthcare facilities, we find that modern pacemakers average 6.2 known vulnerabilities per device, with 43% of deployed devices running firmware more than three years old. The financial implications are substantial: the average cost of a medical device breach has risen to $11.2 million, representing a 34% increase since 2023.

This report provides CISOs with a strategic framework built on four pillars: proactive technical defense, strengthened procedural governance, integrated incident response, and continuous risk assessment. Our analysis of 15 successful device security implementations reveals that organizations following this framework reduce their device-related incident rate by 72% and achieve regulatory compliance 2.3 times faster than those using ad-hoc approaches.

Key findings demonstrate that while no confirmed malicious attacks resulting in patient harm have occurred to date, proof-of-concept exploits have demonstrated the technical feasibility of remote device manipulation, battery depletion attacks, and therapy disruption. The regulatory environment has responded with unprecedented requirements: FDA's Section 524B mandates comprehensive cybersecurity documentation for all new devices, while the EU's MDR treats cybersecurity as a fundamental safety requirement. Organizations must act now to address both legacy vulnerabilities and emerging threats, as the window for proactive defense is narrowing.

Subscribe to CybersecurityHQ Newsletter to unlock the rest.